Cumberland Pharmaceuticals (CPIX) Total Current Liabilities (2010 - 2026)

Cumberland Pharmaceuticals has reported Total Current Liabilities for 17 years, with the latest figure at $34.5 million in Q1 2026.

• Quarterly Total Current Liabilities rose 35.14% year-over-year to $34.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.5 million (up 35.14% YoY) and the FY2025 annual result came in at $36.7 million, up 16.2% from the prior year.
• Total Current Liabilities fell to $34.5 million in Q1 2026 per CPIX's latest filing, from $36.7 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $36.7 million in Q4 2025 and troughed at $24.0 million in Q2 2025.
• A 5-year average of $27.6 million and a median of $26.4 million in 2024 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities surged 48.24% in 2022, then retreated 21.8% in 2025.
• Over 5 years, Total Current Liabilities stood at $28.6 million in 2022, then dropped by 2.09% to $28.0 million in 2023, then rose by 13.01% to $31.6 million in 2024, then grew by 16.2% to $36.7 million in 2025, then fell by 6.14% to $34.5 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $34.5 million, $36.7 million, and $24.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.